Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitors”

753 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 753 results

Testing effectiveness (Phase 2)Study completedNCT05086627
What this trial is testing

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital 118
Not applicableEnded earlyNCT05812274
What this trial is testing

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Columbia University 30
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Testing effectiveness (Phase 2)Looking for participantsNCT07495215
What this trial is testing

A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Yinghua Xu 20
Not applicableStudy completedNCT06007274
What this trial is testing

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Biomarkers
Institut Mutualiste Montsouris 300
Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Not applicableUnknownNCT05288569
What this trial is testing

IrAE Prediction of Anti-PD-1/L1 in Lung Cancer

Who this might be right for
Immune Checkpoint InhibitorsLung Cancer
Peking Union Medical College Hospital 120
Not applicableStudy completedNCT04956783
What this trial is testing

Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen

Who this might be right for
Cancer
University Hospital, Montpellier 500
Not applicableNot Yet RecruitingNCT07321067
What this trial is testing

Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Ahmed Karam Helmy 75
Testing effectiveness (Phase 2)UnknownNCT05311566
What this trial is testing

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Who this might be right for
Cervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more
Lei Li 92
Not applicableLooking for participantsNCT06727981
What this trial is testing

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

Who this might be right for
Advanced Gastric CancerLocally Advanced Gastric Carcinoma
Qilu Hospital of Shandong University 500
Not applicableLooking for participantsNCT05810402
What this trial is testing

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Who this might be right for
Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+2 more
University Hospital, Montpellier 60
Testing effectiveness (Phase 2)Looking for participantsNCT05101070
What this trial is testing

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 282
Large-scale testing (Phase 3)UnknownNCT05910970
What this trial is testing

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular CarcinomaRecurrenceImmune Checkpoint Inhibitor
Guangxi Medical University 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07134413
What this trial is testing

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

Who this might be right for
NSCLC
Guangdong Association of Clinical Trials 77
Testing effectiveness (Phase 2)UnknownNCT05143099
What this trial is testing

Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC

Who this might be right for
Colorectal Neoplasms
Shanghai Zhongshan Hospital 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07599111
What this trial is testing

Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP

Who this might be right for
Pneumonitis, InterstitialImmune Checkpoint Inhibitors (ICIs)Mesenchymal Stem Cells+1 more
Zhou Chengzhi 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07354984
What this trial is testing

A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University 30
Not applicableLooking for participantsNCT05378334
What this trial is testing

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Guangzhou University of Traditional Chinese Medicine 82
Large-scale testing (Phase 3)Looking for participantsNCT06581406
What this trial is testing

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Replimune, Inc. 280
Load More Results